These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 21657888
21. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Fertil Steril; 2005 Jun; 83(6):1717-23. PubMed ID: 15950641 [Abstract] [Full Text] [Related]
22. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC. Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221 [Abstract] [Full Text] [Related]
23. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [Abstract] [Full Text] [Related]
24. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome. Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C. Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756 [Abstract] [Full Text] [Related]
25. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS, Rouzi AA. Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [Abstract] [Full Text] [Related]
26. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061 [Abstract] [Full Text] [Related]
27. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Pehlivanov B, Orbetzova M. Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429 [Abstract] [Full Text] [Related]
28. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. Cho LW, Kilpatrick ES, Keevil BG, Jayagopal V, Coady AM, Rigby AS, Atkin SL. Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853 [Abstract] [Full Text] [Related]
29. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Mitkov M, Pehlivanov B, Orbetzova M. Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219 [Abstract] [Full Text] [Related]
30. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Yilmaz M, Isaoglu U, Delibas IB, Kadanali S. J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088 [Abstract] [Full Text] [Related]
31. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Graff SK, Mário FM, Alves BC, Spritzer PM. Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153 [Abstract] [Full Text] [Related]
32. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B, Mitkov M. Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [Abstract] [Full Text] [Related]
33. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D. Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058 [Abstract] [Full Text] [Related]
34. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. Verit FF. Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438 [Abstract] [Full Text] [Related]
35. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I. Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228 [Abstract] [Full Text] [Related]
36. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors. Carmina E, Campagna AM, Lobo RA. Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974 [Abstract] [Full Text] [Related]
37. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199 [Abstract] [Full Text] [Related]
38. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women. Indhavivadhana S, Wongwananuruk T, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, Popijan M. J Med Assoc Thai; 2010 Jun 16; 93(6):653-60. PubMed ID: 20572369 [Abstract] [Full Text] [Related]
39. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome. Wiltgen D, Furtado L, Kohek MB, Spritzer PM. Gynecol Endocrinol; 2007 Mar 16; 23(3):173-8. PubMed ID: 17454172 [Abstract] [Full Text] [Related]
40. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Fertil Steril; 2007 Nov 16; 88(5):1389-95. PubMed ID: 17462641 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]